• 미 House of Representatives는 목요일 Homeland Security 세출 예산안을 가결하여, 연방 이민, 국경 및 cybersecurity 운영 일부를 중단시켰던 2개월간의 부처 shutdown을 종료하는 길을 열었습니다.
• Donald Trump 대통령은 직후 해당 법안에 서명하여 Department of Homeland Security의 전체 funding을 복구했으며, 이번 회계 연도 말까지 airport security, 추방 작전 및 border enforcement에서 발생할 수 있는 차질을 방지했습니다.
• 이번 shutdown 충돌은 border enforcement 수준을 두고 Trump 측근들과 온건파 Republicans 및 Democrats가 대립했으나, 최종 법안은 일부 hard-line 지출 요구를 완화하면서도 Trump 시대의 핵심 국경 이니셔티브를 유지했습니다.
Lula 대통령의 법안 거부권이 브라질 하원과 상원에 의해 번복되었으며, 이는 현재 대법원의 확정을 기다리고 있음을 의미합니다. 보수 성향이 강한 브라질 의회는 작년 쿠데타 시도 혐의로 유죄 판결을 받은 극우 성향의 Jair Bolsonaro 전 대통령의 형량을 감경하는 법안을 승인했습니다. 이 법안은 당초 12월 의회를 통과했으나, Luiz Inácio Lula da Silva 대통령은 Jair Bolsonaro 지지자들이 수도 Brasília를 약탈한 지 3년이 되는 시점을 상징하는 조치로 지난 1월 거부권을 행사했습니다. 계속 읽기...
• US supreme court가 Voting Rights Act의 핵심 조항을 축소한 것과 같은 날 투표가 실시되었습니다
• Florida 주 의회는 올해 midterms를 앞두고 Donald Trump가 시작한 전국적인 선거구 재획정 싸움의 일환으로, 주 내에서 Republicans의 우위를 극대화하기 위해 고안된 새로운 연방 의회 지도를 승인했습니다.
• 이번 투표는 Ron DeSantis 주지사가 제안서를 공개한 지 불과 이틀 만에, 그리고 US supreme court가 Voting Rights Act의 핵심 조항을 축소한 날과 같은 날에 이루어졌습니다. 이번 결정은 유색인종 유권자의 영향력을 제한하는 방식으로 선거구를 재획정하려는 Republicans의 시도에 Democrats가 이의를 제기하는 것을 더 어렵게 만들 수 있습니다. Continue reading...
• 수천 건의 소송을 해결하는 광범위한 법적 합의가 발효됨에 따라, OxyContin 제조사인 퍼듀 파마(Purdue Pharma)는 이번 주 말까지 해산되고 오피오이드 위기 해결을 목표로 하는 새로운 공익 기업으로 대체될 예정입니다.
• 화요일, 연방 판사는 미국 법무부의 조사를 해결하기 위해 해당 회사에 형사 판결을 내렸으며, 이는 합의를 위한 마지막 필수 단계였습니다.
Leaders will discuss how to respond to surging energy prices amid the war in the Middle EastEurope live – latest updatesEU leaders have welcomed the end of diplomatic deadlock over a long-awaited €90bn (£78bn) loan for Ukraine, after the bloc finalised the agreement along with a 20th package of sanctions against Russia.After weeks of delay, the EU signed off on the loan on Thursday, in time for summit talks in Cyprus that are scheduled to begin in the evening and will include talks over a dinner with the Ukrainian leader, Volodymyr Zelenskyy. Continue reading...
• The FDA granted accelerated approval to a CRISPR-based gene therapy for severe sickle cell disease on April 20, marking the first approved genetic treatment editing patient blood cells to produce functional hemoglobin.
• Clinical trials demonstrated 95% of treated patients experienced elimination or near-elimination of vaso-occlusive crises within 12 months, with durable responses observed for over two years post-treatment.
• The therapy addresses a disease affecting approximately 100,000 Americans, primarily of African descent, offering potential cure for patients previously reliant on pain management and blood transfusions.
The decision to extend a warrantless security law until 30 April came after 20 Republicans worked with House Democrats to defeat attempts to pass five-year and 18-month renewalsSign up for the Breaking News US emailHello and welcome to our live coverage of US politics.The House of Representatives voted early on Friday to briefly extend an expiring and controversial law that grants the US government sweeping powers for warrantless surveillance.Donald Trump announced a 10-day ceasefire in Lebanon to be followed by a meeting between Israeli and Lebanese leaders next week.Progressive Democrat Analilia Mejia won a New Jersey special election for the US House on Thursday. Mejia, who was endorsed by Elizabeth Warren and Alexandria Ocasio-Cortez, is far more critical on Israel and was the only candidate in the Democratic primary to call Israel’s actions during the war in Gaza a genocide.Todd Lyons, the acting director of US Immigration and Customs Enforcement (ICE), is stepping down after a turbulent year carrying out Donald Trump’s immigration agenda.Donald Trump nominated Erica Schwartz, former deputy surgeon general during his first administration, to lead the Centers for Disease Control (CDC).Schwartz was under immediate pressure from critics of the health secretary, Robert F Kennedy Jr, to oppose his anti-vaccine ideology. At a heated oversight hearing, House Democrats grilled Kennedy over his vaccine rollbacks.Speaking in Las Vegas, Trump told supporters “the war in Iran is going along swimmingly, we can do whatever we want.” He did not explain why, then, the US military has been unable to stop Iran from closing the strait of Hormuz.The US Department of Justice opened an investigation into Eric Swalwell following his resignation from Congress, according to a source familiar with the matter.Police in Illinois responded Wednesday evening to the home of Pope Leo’s brother, John Prevost, after a bomb threat was made, NBC Chicago reported. Continue reading...
Legislative change backed by libertarian president makes it easier to extract metals in frozen parts of the AndesArgentina’s congress has approved a bill promoted by the libertarian president, Javier Milei, that authorises mining in ecologically sensitive areas of glaciers and permafrost, and has outraged environmentalists.The amendment to the so-called glacier law, which was already approved by the senate in February, would make it easier to mine for metals such as copper, lithium and silver in frozen parts of the Andes mountains. Continue reading...
• The FDA granted approval on April 7, 2026, to Moderna's mRESVIA vaccine, an mRNA-based shot targeting respiratory syncytial virus (RSV) for adults aged 60 and older.
• Clinical trials showed 83.7% efficacy against RSV lower respiratory tract disease in the first season, with data from over 37,000 participants across 22 countries including US sites.
• This marks the second mRNA RSV vaccine approved after GSK's Arexvy, aiming to reduce 140,000-160,000 annual US hospitalizations among seniors; CDC review expected soon.
Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s WegovyThe US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received approval in December. Continue reading...